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In the UK approximately 1.2 million people have COPD with around  25-40% being 
underweight and 35% have a severely low fat-free mass index. Measuring their body mass 
index is recommended and  Health care professionals should endeavour to ensure that COPD 
patients are achieving their nutritional requirements.  
A narrative review summarizes evidence from 28 original articles identified through a 
systematic searches of databases, grey literature and hand searches covering 15 years, focusing 
on two themes, on the impact of malnutrition on COPD, and the management of malnutrition 
in COPD. 
Malnutrition causes negative effects on exercise and muscle function and lung function as well 
as increasing exacerbations, mortality and cost.  Management options include nutritional 
supplementation which may increase weight and muscle function. Nutritional education has 
short-term improvements.  
Malnutrition affects multiple aspects of COPD, but treatment is of benefit. Clinical practice 
should include nutrition management.  
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In 2016 there were 3 million deaths worldwide as a result of chronic obstructive pulmonary 
disease, COPD,  ranking it the third most common cause of death after ischaemic heart disease 
and stroke. Approximately 1.2 million people in theU.K. have a diagnosis of COPD and its 
incidence is on the rise [1]. COPD is characterised by symptoms of dyspnoea, cough and 
sputum production. Although COPD is not curable it is manageable and the National Institute 
for Health and Care Excellence, NICE (2018) COPD guidelines recommend smoking 
cessation, inhaled therapy and pulmonary rehabilitation [2]. However, before commencing 
pulmonary rehabilitation it is suggested that the patient’s nutritional status is evaluated, and 
action taken based on the result of this assessment [3]. Similarly, NICE (2018) recommend that 
patients with COPD have their body mass index, BMI, calculated routinely [2].  
BMI provides guidance on the nutritional status of the person and places them into one of four 
categories. NICE recommend that if the patient’s weight is abnormal, the best course of action 
would be to refer the patient to a dietician for assessment [2]. Yet these recommendations have 
not been updated since the NICE COPD guidelines of 2004 [4]. Recent studies have estimated 
that 25-40% of COPD patients are underweight while 35% of patients have severely low fat-
free mass index (FFMI) [5]. Fat-free mass is associated with muscle mass and if low it can 
impact negatively on exercise ability and muscle function [6]. As the prevalence of 
malnutrition appears to be high in COPD patients, better recognition is required in order to 
optimise management. NICE states that in the UK ident fying and managing malnutrition is 
inadequate in all health sectors [4]. Malnutrition s defined as a condition where there is a lack 
of nutrients which negatively affects the body’s struc ure and/or ability to function. In addition, 
a diagnosis of malnutrition can be made when there is a low BMI or unplanned weight loss 
with a reduced BMI or a low FFMI adjusted for sex. Furthermore, poor health can cause 










Consequently, appropriate screening tools that are v lidated should be used to assess for 
malnutrition [7].  
Rawal and Yadav (2015) state the exact cause of malnutrition in COPD is poorly understood 
but that several factors such as a raised resting energy expenditure, inflammation, hypoxia and 
medication use may contribute [5]. According to Shepherd (2013) all health care professionals 
must ensure that patients meet their nutritional requir ments to avoid malnutrition [8].  
This review aims to identify the impact that malnutrition has on people with COPD and the 
management options that have been used to improve malnutrition. This will allow 












A combined database search of CINAHL, Academic Search Complete, EBSCO and 
MEDLINE were completed multiple search words and search strings were created to find 
literature. Key search words were “Chronic Obstructive Pulmonary disease” (OR “COPD” OR 
“Chronic Obstructive Pulmonary Disease” OR “Chronic Obstructive Lung Disease), 
Malnutrition (OR “underweight” OR “low BMI” OR “Undernutrition” OR 
“Undernourishment”), “Diet” (OR “Feeding” OR “Eating” OR “Nutrition” OR “Supplements” 
OR “Nutritional Supplementation” OR “Food” OR “Food intake” OR “Inadequate diet” OR 
“Dietary deficiency”), “Management”, “Education” (OR “Advice” OR “Input”). A 
combination of search strings were combined using the Boolean search words, and/or. 
Research finished and/or published between 2004-2019 were included. Other inclusion criteria 
consisted of limiting the research to peer reviewed lit rature published in the English language. 
The database searches were undertaken between July and August 2019. 
Separate searches of Wiley online library, PubMed and Science Direct was completed using 
the above search strings and filters. In addition, grey literature was investigated in order to 
minimise publication bias via Open Grey, NHS RightCare Casebooks and the World Health 
Organisation International Clinical Trials Registry Platform (ICTRP). Finally, hand searches of 
prominent journals in respiratory medicine were conducted. Thorax and European Respiratory 
Journal were searched via online editions for publications related to nutrition/malnutrition and 
COPD. Other hand searches included examining referenc  lists of research studies and other 
journal articles related to the current topic. Exclusion criteria were studies that examined 
malnutrition in people during exacerbation or those who were obese, malnutrition management 
of the obese COPD patient, and studies which examine the effect of specific supplements such 
as whey protein and vitamins. In addition, research which reports the effect of enteral feeding 










In total, database searches yielded 2,881 publications which were narrowed down by title. 
Following removal of duplications there were 33 research articles to be included for further 
review by title and abstract. Grey literature yielded twenty-five hits, however 24 were not 
appropriate for inclusion. One study seemed appropriate by title, but access to the study or 
abstract was not possible. In addition, searches of Th rax found five publications which were 
suitable for further review. European Respiratory Journal was searched based on inclusion and 
exclusion criteria and based on full text availability only one article was suitable for review. 
Similarly, scanning of reference lists uncovered seven studies which were evaluated. 
Duplicates were removed before studies were reviewed by title and abstract. A total of 28 













The 28 studies reviewed were conducted principally in Europe and Asia, 19 examined the 
impact of malnutrition on patients with COPD. Seven studies explored the effect of oral 
nutritional supplementation on people with COPD while two studies trialled counselling as an 
alternative (Table 1 and 2).  
1. Impact of malnutrition on COPD  
1.1 Exercise ability and muscle function 
Dyspnoea inhibits mobility and general exercise which can result in an inability to complete 
daily activities. Consequently, muscle wasting can occur  [9]. Yet Holst et al. (2019) undertook 
a cross-sectional study to examine whether a relationship between nutrition and physical ability 
existed [10].  
The study included 79 people with a varying severity of COPD who were recruited from five 
pulmonary rehabilitation centres in Denmark. To obtain information about the patient’s dietary 
intake a 3-day diary was completed as well as an additional 24-hour food recall at the time of 
the diary collection. However, it is unclear what the total population was so there is the risk of 
selection bias. Furthermore, the patients had other co-morbidities which could affect 
malnutrition. Yet, this makes the study more ‘real world’ as patients in the clinical setting can 
have more than just one illness [11]. The study found that protein intake below 75% of the 
recommended requirements was positively associated to a six-minute walk test,  6-MWT, 
(<75% Mean 6-MWT=332 ± 115 M, ≥75% Mean 6-MWT=393 ± 108 M, P = 0.023). 
However, an energy intake below 75% of the recommended requirements was not associated 
with a reduced 6-MWT (P = 0.388). Conversely, a reduc  energy intake was associated with a 
poorer 30 second–chair stand test, 30s-CST, (P=0.01) when linear regression was applied 










In contrast, Lee et al. (2013) found that an estimated energy requirement, EER, below 75% 
was associated with a shorter 6-MWT (<75% EER 337 ± 84 M, ≥75% EER 366 ±80 M, P = 
0.008) [12]. While those patients with higher calorie intake had a longer 6-MWT. This study 
was also a cross-sectional descriptive study and patients were recruited from five respiratory 
outpatient departments in South Korea. There was a l rger sample size of 251 patients in 
comparison to Holst et al. (2019) [10] and patients mostly had mild to moderate disease 
severity. However, collection of information regarding dietary intake relied solely upon a 24-
hour food recall method and there is the risk of underreporting with this tool [13].  
In addition, total calorie, protein, iron and carbohydrate intake were significantly linked to the 
6-MWT (P<0.001, P = 0.001, P<0.001 and P = 0.002 respectively).  
Similarly, Katsura, Yamada and Kida, (2005) undertook a cross-sectional study in an 
outpatient department in Japan and found that COPD patients classified as underweight based 
on a BMI of ≤ 20kg/m2 had a significantly lower 6-MWT than those who had a normal weight 
(underweight: 349 ± 18 M, normal weight: 396 ± 9 M, P<0.05) [14]. Conversely, a cohort 
study in Spain found no difference in 6-MWT between those who were malnourished (387± 
119 M) and nourished groups (401 ± 119 m ) [15].  
Luo et al. (2016) also conducted a cross-sectional study in a respiratory clinic. The aim was to 
assess the relationship between nutrition and exercise ability, symptom burden and respiratory 
muscle function [16]. A sample size of 251 people of all disease severities were included but of 
these only 51 were female. The data show a weak correlation between a low FFMI and a 
shorter 6-MWT distance where r = 0.26 and P< 0.001.  
Similar results were not seen in a cross-sectional study conducted by Hallin et al. (2011) in 
Sweden [17]. This study was smaller and only consisted of 49 COPD patients with moderate to 










one centre. The study did not find any correlation between FFMI and a 12 minute walking test, 
12-MWT, distance or incremental shuttle walk test, ISWT, P = 0.2 and P = 0.56 respectively.  
The BMI was not related to ISWT or 12-MWT (P = 0.4 and P = 0.9 respectively). Furthermore, 
peak working capacity in watts (Wpeak) positively correlated to FFMI and BMI (coefficient: 2.8 
and 1.5 respectively, P = 0.01). Also, FFMI, arm and leg circumference were significantly 
related to hand-grip strength (coefficient=18, P = 0.001, coefficient = 8, P = 0.007 and 
coefficient = 5.7,  P<0.0001 respectively). Hand-grip strength is a predictor of mortality as well 
as physical frailty [18]. A similar result was seen in a cross-sectional study conducted in the 
Netherlands where handgrip strength was significantly lower in the malnourished group verses 
the nourished (31 ± 9 verses 38 ±11 kg) where P <0.01 when adjusted for sex). Handgrip 
strength showed a weak correlation to FFMI with  r = 0.22 and P<0.001 [6].  
Finally, Mkacher, Tabka and Trabelsi (2016) carried out a cross-sectional study in Tunisia to 
establish whether a relationship existed between balance, nutrition, exercise ability[19]. The 
participants had moderate to severe COPD. Nutritional status was assessed using the MNA 
which has been shown to be a reliable tool when assessing nutrition in COPD patients [20].  
Balance was assessed using multiple techniques; Timed Up and Go test, TUG, Unipodal 
Stance Test, UST, Tinetti test and Berg Balance Scale, BBS. TUG has been shown to be valid 
and reliable at measuring patients’ risk of falls. Tinetti is also a tool to assess patients’ risk of 
falls. UST measures the patient’s ability to stand o  foot for 45 seconds. BBS was used to 
assess the patients functional balance. It was shown that those who were at risk of falls and had 
poor balance had a shorter 6-MWT (P<0.05). However, those with lower MNA scores (at risk 
of malnutrition) had significantly reduced scores measured by TUG and Tinnetti (P<0.01). 
Furthermore, the balance scores were also significatly correlated to BMI and 6-MWT (except 










1.2 Disease severity   
The aim of COPD management is to prevent disease progression [21]. Consequently, 
Humphreys et al. (2008) undertook a cross-sectional study in a respiatory outpatient 
department in Australia with the objectives to asses  if malnutrition was related to lung 
function and quality of life [22]. Sixty six patients with moderate COPD were recruited and 9 
patients did not complete the diary. There was no significant difference in age, lung function, 
BMI or FFMI between those that did complete the diary and those that didn’t. FFMI was 
measured using a tetra-polar bio-impedance spectroscopy. This test is easy to use and reliable 
in healthy people with normal hydration but may notbe as reliable in those with electrolyte 
imbalances or exceptionally high or low weight [23]. The study showed that a low BMI and/or 
decreased FFMI was linked to a reduced forced expiratory volume in one second, FEV1 (P = 
0.003) and worse obstruction (P = 0.038) than those with normal body composition. A weak 
correlation between FEV1 and BMI was seen (r = 0.310 and P = 0.015) while FEV1 and FFMI 
exhibited a weak correlation only in male participants (r = 0.373 and P = 0.046). In 
comparison, Yazdanpanah et al. (2010) carried out a cross-sectional study in Iran [24]. Patients 
were recruited when acutely unwell in hospital but were stable at the time of the study. Sixty 
three patients with stage 2-4 COPD as per GOLD guidelines were included. Patients kept a 24-
hour food diary for the previous day and a food frequ ncy questionnaire, FFQ. The stability of 
the patients and if they were at home when completing the diary is unclear. FFQ was used as 
an acute exacerbation may affect dietary intake. However, if the patient was stable then dietary 
intake should be normal. The results showed that protein and energy intake were not 
significantly correlated to FEV1 from either tool. However, it is reported that protein intake 
from the FFQ was correlated to the forced vital capacity, FVC,  P = 0.02, r = 0.2  and to  vital 
capacity, VC,  P=0.008, r = 0.3. Another cross-sectional study was undertaken by Baig et al. 










BMI and mid-upper arm circumference, MUAC [25]. One hundred and thirty eight patients 
were included, and the mean percent predicted FEV1 was 28 ± 5%.  
It is reported that lung function tended to be in the very severe category in those malnourished 
according to BMI (P = 0.001) and MUAC (P<0.001) butonly 21 patients had severe COPD.  
Luo et al. (2016) found that as COPD severity worsened patients’ malnutrition as measured by 
FFMI also deteriorated (FFMI ≤15kg/m2 for men and ≤16kg/m2 for women) [16]. The most 
severe had a significantly worse FFMI (P<0.001). The correlation between FFMI and FEV1 
percent predicted was low (r = 0.17, P = 0.01).  
In comparison, a cross-sectional study carried out in Turkey by Dilektasli et al. (2009) found 
that BMI was positively correlated to FEV1 (r = 0.457 and P = 0.007) [26]. In the study were 
35 participants with moderate to severe COPD. This study also found that those categorised as 
cachectic had significant difference in FEV1 and diffusion capacity, DLCO, in comparison to 
those that were non-cachectic (FEV1: 1.3 ± 0.6 L versus 1.6 ± 0.9 L, DLCO: 3.9 ± 1.6 versus 
6.2 ± 2.0 mmol/kPa/min, P<0.05). Cachexia is described as severely low body weight as a 
result of reduced tissue mass other than fat [27]. Correspondingly, Gupta et al. (2014) 
undertook a cross-sectional study in an outpatient d partment in India to assess whether a 
relationship existed between BMI and oxygen saturations [28]. Patients (n = 147) with different 
COPD severities were included and BMI decreased as severity worsened (P<0.001). Also, 
peripheral capillary oxygen saturation, SpO2 as measured by a pulse oximeter was inversely 
linked to BMI.  
1.3 Exacerbation, mortality and associated cost  
COPD exacerbations lead to decreased quality of life, reduced lung function and an increased 
risk of mortality. Exacerbations can occur due to viral or bacterial infection or inhaling a 










cohort study of 87 people with COPD that being underweight or losing weight increased the 
risk of an exacerbation [29]. This Swedish study recruited patients when they were acutely 
unwell and followed them up one year later at home. Prior to the one-year review patients 
completed a seven-day food diary. However, only 41 patients were included due to incomplete 
data, diaries or death. Twenty four patients had an exacerbation, and participants who were 
underweight or normal weight were no more likely to exacerbate  (P = 0.07). Furthermore, 
weight loss and a low BMI was found to decrease the tim  until the next exacerbation when a 
multivariate analysis was applied (BMI risk ratio: 0.78 95% CI: 0.65-0.93 P=0.003, Weight 
change: 0.76 95% CI 0.63-0.93 P=0.006). Yet, a cross-sectional Turkish study found that the 
rate of exacerbations was not affected by malnutrition (P = 2.37, odds ratio (OR): 0.234 95% 
CI 0.021-2.592) [30].  
Hallin et al. (2006) also mention a small increase in weight in some patients in the underweight 
group within one year, which suggests patients may have lost weight just prior to their 
exacerbation [29]. Also, the results showed that the underweight group had 1.2 ± 1.2 
admissions during the 12-month period whereas the normal group had less at 0.3 ± 0.6, P<0.05.  
Similarly, Lee et al. (2013) found through a Χ2 analysis of 251 patients, 21.1% of those with a 
low energy intake had attended the emergency department in the previous 6 months verses 
8.2% of those with normal or above normal intake (x2=6.661, p=0.012) [12].  
Marco et al. (2019) conducted a cohort study at a Spanish pulmonary rehabilitation to assess 
the impact of malnutrition on hospital admission and mortality[15]. The study lasted for two 
years and included 118 patients with moderate to very s vere disease. The study showed that 
67 % of patients required at least one hospital admission. Those that were identified as being 
malnourished using European Society for Clinical Nutrition and Metabolism, ESPEN,  criteria 










53.5) days in malnourished patients, compared to 9 (3, 20.5) days in patients who were 
nourished (P = 0.041). When variables (age and lung f ction) were adjusted the findings were 
still of significance. In addition, the 2-year mortali y risk was increased when malnutrition was 
diagnosed by ESPEN (Hazard ratio, HR: 3.85 95% CI 1.4-10.62, P = 0.009) and by using the 
Mini-Nutritional Assessment tool Short form, MNA-SF (HR 3.96, 95% CI: 1.12-14.03, 
P=0.033). The MNA-SF has been shown to be a valid tool for assessing malnutrition [31]. Low 
FFMI increased the risk of mortality 17 times (HR 17.06, 95% CI: 2.24-129.82, P = 0.006).  
Schols et al. (2005) conducted a large cohort study over five years in the Netherlands where 
patients were also recruited from a pulmonary rehabilit tion centre [32]. The study recruits (n = 
412) were allocated to one of four categories; cachectic, semi-starvation, muscle atrophy and 
no impairment. During the study 46% of patients died. BMI, FFMI and fat mass index were 
significantly associated with an increased risk of death (Relative risk: 0.94, 95% CI 0.90, 0.97, 
P=0.001, RR: 0.88, 95% CI 0.83, 0.94, P=0.001, RR: 0.93, 95% CI 0.88, 0.99, P=0.009 
respectively). In addition, Cox regression models showed that FFMI was an independent 
predictor of mortality with and without alterations for stage of disease (RR: 0.90, 95% CI: 
0.84, 0.96 P=0.003). However, FFMI was a better predictor than BMI of mortality risk.  
Similarly, Hoong et al. (2016) undertook a cohort study in Australia where 834 patients were 
included after being identified as having had lung function testing completed [33]. The 
admissions to hospital were monitored for one year and mortality was assessed at year 1 and 2. 
There were 286 admissions, but patients may have been admitted to other local hospitals 
meaning the admissions could have been missed. 
Patients that were admitted tended to have a lower BMI (27.4 ± 6.6 kg/m2 in comparison to 
28.6 ± 7.3 kg/m2,  P = 0.016), although the level would not be considere  underweight. 










year and 2 years (27.7 vs 12.1 %, P = 0.006 and 40.4 vs 18%,  P = 0.001). When confounding 
variables were removed (age, lung function, DLCO and BMI) malnutrition was still a strong 
factor in associated mortality at 1 year. The OR was 2.93 95% CI 1.10, 7.93 and P=0.009. Cox 
regression was also applied, and malnutrition was significantly important when assessing 
mortality risk (OR: 0.42 95% CI 0.19 – 0.91 P=0.028). Patients with malnutrition also had a 
longer length of stay, 11.6 ± 11 days, in comparison to 6.7  ± 10.2 days in nourished patients 
P = 0.003). Consequently, hospitalisation cost was increased in the malnourished group 
$23,652 ± 26,472) versus $12, 362 ± $21,865,  P=0.002.  
Larger cohort studies have also examined nutrition and mortality in COPD. McDonald et al. 
(2017) conducted a retrospective cohort study which combined data from the ECLIPSE study 
and the COPDGene study which included 12 countries and in 21 centres in the USA 
respectively [34]. The ECLIPSE study had 1,518 participants while the COPDGene study had 
3,121. A calculation was tested on half of the ECLIPSE patients to measure the pectoralis 
muscle area, PMA, and then applied to all the other patients. FFMIPMA of <16kg/m
-2 for men  
higher risk of death than those above these values. When variables were accounted for and Cox 
regression was applied then a low FFMIP A was still linked to an increased risk of death by 
60% (HR: 1.6, 95% CI 1.2-1.8 P<0.001). In the COPDGene study there were 729 deaths.  
McDonald et al. (2019) also undertook a low bias study when they examined the prevalence of 
cachexia and the link with mortality, COPD severity and BMI [35]. Similarly, data was 
obtained from the cohort study ECLIPSE and 1,483 patient’s data was suitable for inclusion. 
The duration for these patients was 3 years. The standard BODE test was adjusted to replace 
the B for BMI with a C for cachexia or W for weight loss. BODE represents BMI, airflow 
Obstruction, Dyspnoea and Exercise capacity and is used to assess patients’ risk of hospital 
admission and death [9]. Patients with cachexia were more likely to die using all tools when 










history, sex, age and BMI) were controlled for and cachexia was still linked to an increased 
risk of death as assessed by CODE and WODE (Hazard ratio: 3.2, 95% CI 1.6-6.6, P = 0.001, 
Hazard ratio: 3.2 95% CI: 1.8–5.6, P<0.001 respectiv ly). Furthermore, COPD patients were 3 
times more likely to die if they were cachectic.  
1.4 Quality of life and symptom burden  
Assessing QOL in chronic illness has become central to disease management. Katsura, Yamada 
and Kida, (2005) studied the effect that malnutrition has on the QOL of people with COPD 
[14]. The sample consisted of 83 patients who were r cruited to the cross-sectional study from 
an outpatient department in Japan. Participants were categorised as underweight (BMI 
≤20kg/m2) or normal weight (≥20kg/m2 BMI ≤26kg/m2). The participants needed to complete 
The Saint Georges Respiratory Questionnaire (SGRQ) and the SF-36 questionnaire. These had 
been translated into Japanese and to ensure the validity they were then re-translated back into 
English. The underweight group had worse scores in all the categories of SGRQ than the 
normal weight groups (Total score: mean difference: 12.83 P<0.05, Symptoms: mean 
difference: 9.28 P<0.01, Activity: mean difference 13.06 P<0.05 and Impact: mean difference: 
14.44 P<0.05). Breathlessness had the largest impact on SGRQ after multiple regression was 
applied, but BMI was a contributing factor. All the results from the SF-36 were lower in the 
underweight group. Physical functioning, role emotional, bodily pain and general health were 
significantly worse (P<0.05 for all measurements except for bodily pain where P<0.001). Like 
SGRQ, BMI affected role emotional, bodily pain and general health as assessed by SF-36. 
Breathlessness was worse in the 34 participants who were considered underweight as measured 
by the oxygen cost diagram (OCD) (62.47 ± 3.3 versus 77.67 ± 2.3, P<0.001).  
Similarly, Mete et al. (2018) found that malnutrition was more of a risk in patients with an 










was significantly worse where the OR was 22.9 95% CI (2.1-249) and P = 0.010. These data 
were obtained from a cross-sectional study which inluded 105 people, 80% of the participants 
were recruited from outpatient department and the or 20% consented while acutely unwell 
in hospital. Although Lee t al. (2013) found that total calorie, protein, iron and carbohydrate 
intake was inversely correlated to mMRC (r = -0.18, P = 0.004, r = -0.13, P = 0.043, r = -0.15 P 
= 0.021 and r = -0.14,  P = 0.025 respectively) [12]. Similar findings were not seen in a study 
conducted by Vermeeren et al. (2006) [6]. This study used data from a single visit collected 
during the double-blind intervention study in 39 centr s in the Netherlands, 389 people with 
stage 2 and 3 COPD were included and categorised as nourished or nutritionally depleted 
(defined as BMI ≤21kg/m2 and/or FFMI of ≤15kg/m2 (females) or ≤16kg/m2 (males)). 
However, breathlessness as measured by the MRC did not vary between groups. In addition, 
SGRQ scores were not significantly different between groups. Equally, Humphreys et al. 
(2008) didn’t find any difference in quality of life measured by SGRQ between those with a 
low BMI ± FFMI and those with normal body composition [20].  
2. Management of malnutrition  
Given the impact of malnutrition on COPD it is imperative that management options are 
understood by health care professionals providing care to patients with COPD. Knowledge of 
the benefit and weakness of treatment options are required so that patients can make an 
informed decision. Consequently, this will mean that ealth care professionals can obey the 
ethical principles of autonomy, beneficence and non-maleficence [36]. Furthermore, this 
knowledge is particularly relevant for nurses, as they are normally the first people to identify 
poor nutrition and therefore have an important rolein managing malnutrition [37].  









Oral nutritional supplements (ONS) are used during acute illnesses but also for those with 
chronic long-term conditions who find it challengin to meet their daily nutritional 
requirement. They should be used in conjunction with meals and not as a meal replacement 
[38]. Yet COPD patient’s energy requirements may be greater than their peers without COPD 
[5]. Planas et al. (2005) undertook a randomised trial over 12 weeks in Spain to explore the 
effect of two different nutritional interventions on the quality of life of people with COPD [39]. 
Baseline measurements were taken and both groups had diet ry intake requirements calculated 
but for group A this was multiplied by 1.7 and for group B it was multiplied by 1.3. To achieve 
the daily energy requirements all patients needed ONS’s. Quality of life scores from the 
Chronic Respiratory Disease Questionnaire (CRDQ) did not improve significantly. However, 
this had been translated to Spanish. In group A, body weight was significantly improved from a 
mean 55.3 ± 8.1 to 58.5 ± 9 kg (P = 0.001). Skin fold thickness improved (P = 0.02). However, 
FFMI reduced from 14.6 ± 1.3 to 13.9 ± 1.6 kg/m2 (P = 0.02). Also, lung function decreased 
along with handgrip strength. Group B did not gain weight (55.2 ± 8.6 to 55.6 ± 9.6 kg) nor did 
fat mass change. FEV1 improved to 40.4±17.7 % predicted from 37.3 ± 18.5 % predicted. The 
authors conclude that an addition of 1.3 to dietary intake is superior and does not negatively 
affect respiratory function.  
Similarly, Broekhuizen et al. (2005a) compared the effect of smaller volume ONS to larger 
volumes in a retrospective control trial in the Netherlands [40]. The population were patients 
admitted to a single pulmonary rehabilitation centr and identified as malnourished. Nineteen 
COPD patients (group A) admitted between 2000-2002 requiring three 125ml cartons of ONS 
were matched against 20 patients also admitted to the rehabilitation centre between 1995-1997 
(group B) and received three 200ml cartons of ONS.  
After two weeks the participants took part in an 8-week exercise programme which comprised 










difficult due to assessments being compared with retrospective data. Group A and B had 
significant increases in body weight and FFM from baseline (weight change: 3.3 ± 1.9 kg and    
2.0 ± 1.2 kg, P<0.001, FFM group A: 2.2 ± 2.0 kg  P<0.001 and group B 1.4 ±1.9 kg, P = 
0.004). While fat mass, FM was greatly improved in A (1.1 ± 1.3 kg, P=0.002), this was not 
seen in B. Also, group A gained more weight than those in B which was significant (P=0.019). 
SGRQ changes were not statistically significant in either group, however there was a clinically 
significant change in group A where the total score decreased by 4 points. The exercise ability 
measured by incremental bicycle ergometry test was improved in A and B but did not differ 
between groups (A, 8·3 ± 17.1 W, within-group change P=0·062; group B, 9·0 ± 9.4 W, 
within-group change P = 0·002; between-group change, P=NS). Lung function did not change 
significantly.  
Sugawara et al. (2010) undertook a prospective randomised control trial in Japan with patients 
receiving nutritional support in combination with an exercise regime [41]. COPD patients (n =   
32) with moderate to severe disease were recruited from a pulmonary rehabilitation centre. To 
be eligible patients had to have a BMI of less than 19kg/m2. Patients were randomised to either 
the intervention or control group.  
The intervention group were given two ONS drinks which provided 400 kCal per day. Both 
groups received a 45-minute education class once a month. Following 12 weeks of ONS, the 
intervention group had an improvement in body weight and fat free mass in comparison to the 
control group (P = 0.002 and 0.038 respectively). The total CRDQ change was significant (P = 
0.028). This tool had been translated into Japanese and validated previously. In addition, the 
intervention group had better 6-MWT, quadricep muscle force and maximum inspiratory 










In contrast, Gurgun et al. (2013) showed 6-MWT and ISWT were not altered by adding ONS 
to pulmonary rehabilitation  in a Turkish randomised control trial [42]. Malnourished patients 
with severe to very severe COPD admitted to a pulmonary rehab centre were randomised to 
one of three arms; pulmonary rehabilitation only (PR), pulmonary rehabilitation and ONS 
(PRNS) or control. The 46 patients completed the 8-week programme and then received 16 
weeks of normal care. The PRNS group received three 250ml drinks to consume in addition to 
their normal meals. Quality of life scores were significantly improved in the PR group in all 
areas as measured by the SGRQ (p<0.05). However, the PRNS had improvements SGRQ 
except for the impact section (P = 0.112). The PRNS group had 10 patients with anxiety and 8 
of them had depression (two patients needed to start anti-depressants). In the PR group five 
patients suffered from anxiety and seven with depression.  
After treatment the PRNS group had four patients wih anxiety and six with depression, while 
the PR group continued to have two with anxiety andfive were depressed. Anxiety improved 
in participants in the PR and PRNS groups (P = 0.001 and P = 0.007 respectively) but 
depression was unchanged. Body weight increased in the PR and PRNS groups significantly 
(1.1 ± 0.9kg, P = 0.002 and 0.6 ± 0.7kg, P = 0.007 respectively). In comparison to the controls 
the results were significant (P = 0.001 and P<0.001, respectively). The PRNS had a greater 
increase in body weight, BMI, FFMI in comparison to the PR group (P<0.05). Mid-thigh CSA 
increased greatly in the PRNS group (2.5 ± 4.1 cm2, P = 0.011). Yet the PR and control group 
did not see any improvement.  
Furthermore, the results of a Danish randomised control trial showed that nutritional support 
did not improve ISWT (P=0.91) [43]. COPD patients (n =53) with varying severity were 
recruited from a pulmonary rehabilitation centre. Patients were randomised to an exercise only 
group or an exercise group plus nutritional support. The nutritional support came in the form of 










exercise only group and exercise plus nutritional support group was 24.3 ± 3.9 and 23.4 ± 4.3 
kg/m2 respectively.  
Similarly, van de Bool et al. (2017) found that nutritional support in combination with exercise 
did not yield better 6-MWT in comparison to an exercise only group [44]. This study was a 
randomised placebo-controlled study that took place in five pulmonary rehabilitation centres in 
the Netherlands. For inclusion in the study patients had to have a FFMI less than the 25th 
percentile for sex and age. The intervention group was given an ONS drink of 125ml 
containing 187.5 Kcal and the control had a placebo drink over 4 months. Afterwards there was 
an 8-month maintenance period. The nutrition group had an increase in fat mass (pre: 19.8 ± 
1.1, post: 21 ± 1.1 kg, P<0.001) and body weight (pre: 63.8 ±1.7 kg, post: 65.7 ± 1.7 kg,  
P<0.001). The between-group difference in body weight and fat mass was of importance 
(P<0.05 and P<0.01 respectively). Skeletal muscle mass was substantially better in both groups 
but between group difference was not significant (placebo; pre: 18.5 ± 0.6,  post: 18.8 ± 0.6 kg,  
P<0.001 Nutrition; pre: 17.2 ± 0.6, post:17.8 ± 0.7kg, P<0.001). Improvements were seen in 
CET and quadriceps muscle strength (P<0.001 for both in the nutrition group, and in the 
placebo group P<0.001 for CET and P<0.01 in quadriceps muscle strength), but no difference 
was identified between groups. The nutrition group continued to have a stable daily step count, 
but the placebo group decreased. The between group difference was significant (P<0.05). 
HADS total score was pointedly better in the nutrition group and the placebo (P<0.001 and 
P<0.01 respectively). No between group difference was identified.  
This study had an extension, in which patients were followed-up 3 months after the 8-months 
maintenance phase. After 12 months there was no difference between the intervention and 
control group in terms of CET and QMS. Yet, activity levels were lower in the placebo group 
than in the intervention group (P = 0.05). Steps were significantly greater in the intervention 










(P = 0.05). The EQ-5D scores were significantly better in the nutrition group (P = 0.034). The 
results of the EQ-5D was correlated to body weight change (r = 0.406, p = 0.008).  
2.2 Nutrition advice and education  
A systematic review has found that compliance with oral nutritional support is good at 78% 
[45]. Nevertheless, patients report difficulty with oral nutritional supplementation due to poor 
taste and side effects like nausea, vomiting and diarrhoea [46]. Consequently, an alternative 
method may be required. Dietary counselling has been studied as a method to support 
nutritional needs and increase body composition. Weekes, Emery and Elia (2009) undertook a 
randomised control trial in the UK of patients with COPD in the outpatient setting who were 
labelled as being at risk of malnutrition [47]. The patients were randomised to either the control 
or the intervention group. The intervention lasted for six months and then the patients were 
followed-up six months later. The intervention arm was provided with a leaflet about dietary 
intake and with milk fortification supplements. In addition, patients were offered dietary 
counselling. Similarly, the control group were given the leaflet and milk supplementation, but 
none received any education or advice about dietary intake.  
Patients were seen at baseline and then month 1, 3, 6, 7, 9 and 12. Sixty six patients were 
investigated within a population (n =125) that were suitable based on inclusion and exclusion 
criteria. However, by the end of the study only 37 patients remained. The authors report that 
the main reason for participants dropping out was due to a deterioration in health. The 
difference in characteristics between patients that dropped out and remained was not 
significant. To reduce data collection disparities he same person undertook all assessments. 
Dietary intake at baseline was calculated using a rec ll method but for all other visits a 5-day 
diary was completed. The diaries were analysed by two dieticians who were blinded. After the 










protein (2,064 kcal versus 1,715 kcal, P=0.02 and 77.1g versus 56.9 g,  P<0.001 respectively) 
in comparison to the control group. Yet, this significance was not seen at the follow-up point. 
Furthermore, it was noted that 24 participants from the intervention group used the milk 
powder supplement for 14 days or more but nobody from the control group did. The 
intervention group gained weight and managed to maintain this during the follow-up period, 
unlike the control group who lost weight as the study took place (3.1 (0.5-5.7) 95% CI P=0.02). 
Similarly, the control group lost muscle mass and fat mass, but the intervention group gained 
both. The difference in the sum of four skinfold thickness was significant between the groups 
when measured by intention-to-treat at six and twelve months (difference 6.6 mm, P=0.02; 12 
months: difference 9.7 mm, P = 0.01).  
Yet, the difference in mid-upper arm muscle circumference was not of important at the sixth 
month but was at the twelfth month (difference 0.9cm, P = 0.04). SGRQ total scores were 
better in the intervention group from the intention t  treat analysis (53.4 ±2.2 versus 61.1 ± 
2.4, P = 0.02 at six months, 50.6 ± 2.7 versus 63.9 ± 2.8, P=0.002 at 12 months). The impact 
scores were significant (P = 0.004), but the symptos and physical activity were not (P = 0.73 
and P = 0.06 respectively). Likewise, intention to treat analysis showed SF-36 scores were 
better at 6 and 12 months in the intervention group (P = 0.001 and P = 0.003 respectively). Yet 
the MRC score was improved in the intervention group (difference in 1-point P = 0.03). The 
Townsend score was not statistically significant (difference 1.5, P = 0.06).  
Similarly, Farooqi et al. (2010) undertook an intervention study in Sweden to explore the effect 
of nutritional education on people with COPD [47]. Patients were recruited from a pulmonary 
rehabilitation centre following referral but did not complete any specific exercise programme 
during the period. The study does not describe whether patients received this support after the 
study. Forty one patients were included in the study, and 36 at the follow-up period, as one had 










Patients were provided with education about COPD indiv dually and as part of a group by the 
multi-disciplinary team. Recommended dietary intake was calculated for each patient and 
advice given based on current intake. The method of data collection included patients 
completing a 24-hour food recall diary at baseline but at the 3-month and 1-year follow-up they 
completed a 3-day food diary. At the initial visit 17 patients were underweight, 18 had normal 
weight and 6 were overweight. Like Weekes, Emery and Elia (2009) [47], body weight at 3 
months and 1 year had increased significantly (1 ± 2kg, P<0.004 and 1.3 ± 3kg P<0.02). 
Handgrip strength had also improved at 3 months (1.4 ± 3.4 kg, P = 0.02). However, at one 
year the change was no longer significant (P = 0.07).  
Walking distance had improved significantly at 3 months and 1 year (95.1 ± 118.3 M, P = 
0.001 and 83.2 ± 170.1 M, P = 0.007). Additionally, energy intake was noted to be 
significantly greater at 3 months and 1 year (13.9 ±18.4 %, 15 ±17.5% respectively, P<0.001). 
Similarly, protein intake at 3 months had improved significantly (8.3 ± 21.9 %, P<0.03) but at 












The available literature shows that malnutrition has many negative effects on people with 
COPD. Malnutrition measured by BMI or FFMI may affect the distance that patients can walk. 
Six of the studies examined this relationship but only ne study found that 6-MWT was not 
related to nutrition (Table 1). These studies were all moderate quality but Marco et al. (2019) 
was of marginally higher quality and found no relationship [15]. Yet they were all at risk of 
selection bias while Luo et al. (2016), [16] and Holst et al. (2019) were at risk of study design 
bias [10]. Furthermore, Hallin et al. (2011) did not show that malnutrition affected exercise 
ability [29]. However, this study used an alternative exercise test to the 6-MWT in the form of 
the 12-MWT which has been linked to patients tiring due to the increased time [49]. 
Malnutrition was found to be positively related to hand-grip strength in two studies of 
moderate quality [6, 29]. In addition, only one study examined the effect malnutrition has on 
balance and the risk of falls [19]. This study found that malnutrition was related to these 
variables. This was a study of moderate quality, but the risk of potential bias was apparent. In 
addition, all the sample were male. It is noted that e method to identify malnutrition is 
different but also comparator groups are different. Some studies used BMI [10, 14] and some 
used dietary intake [12] and others [16] used FFMI or both FFMI and BMI [15].  
While the assessment method used may affect the outcome,  the review shows that there is no  
link between nutrition status, exercise and muscle tr ngth.  
The association between severity of disease and malnutrition has been examined in six studies 
but one low quality study showed that dietary intake was not related to FEV1 but was to FVC 
[24]. Nevertheless, three of the studies were of low quality while the other three were 









in two [16,24]. Channelling bias was probable in the study by Baig et al. (2018) [25]. It 
appears that malnutrition is present in those with orse COPD.  
Muscle strength is likely affected by poor nutrition which could potentially worsen respiratory 
muscle function coincidently. Yet, it is challengin to understand whether malnutrition causes 
worsening of COPD, or vice versa, but as a result of the research available it is not possible to 
make a firm conclusion. There has only been a weak or low correlation shown. Nevertheless, 
most of the studies have included GOLD stage 2-4 COPD and have shown malnutrition in all 
categories but poorer nutrition is more prevalent in GOLD stage 4.  
In addition, there were conflicting findings on the effect of malnutrition on exacerbation rate. 
Hallin et al. (2006) [29] found the rate was increased but Mete et al. (2018) did not [30]. 
Therefore, exacerbation may be affected.  
Furthermore, hospital admissions and mortality rates r  increased along with cost to the health 
system. The findings were produced from six studies and five of these were moderate quality 
and one was high quality (Table 2). There was the pot ntial for selection bias in four of the 
studies. Nevertheless, these findings are in an era where financial constraints are prominent in 
the NHS and the budget per person has dropped. Consequently, funding must be spent in a 
more sensible manner and in a way that reduces further costs. As mortality is significantly 
affected, malnutrition management should be incorporated into patient care. Yet it is not clear 
how many patients are routinely screened for malnutrition as part of their routine care. 
Odencrants, Ehnfors, and Ehrenberg (2009) discuss how many nurses in primary care have 
been found to assess nutrition based solely on previous experiences [50]. Additionally, health 
care professionals endeavour to improve the life of the patients by delivering holistic care.  
Quality of life is an important measurement and various assessment tools have been used in the 










by malnutrition. Katsura, Yamada and Kida, (2005) [14] report that it is, but Vermeeren t al. 
(2006) [6] and Humphreys et al. (2008) [22] found no difference. Veremeeren et al. (2006) [6] 
was a much larger study and like Humphreys t al. (2008) [22] patients were classified based 
on BMI or FFMI. This is dissimilar to Katsura, Yamada and Kida, (2005) who categorised 
patients based on BMI only [14]. All three studies were of moderate quality. Vermeeren t al. 
(2006) [6] also found no difference between groups in breathlessness score measured by MRC 
while Mete et al. (2018) [30] and Lee t al. (2013) [12] did find a difference with mMRC. 
Similarly, Katsura, Yamada and Kida, (2005) found breathlessness was worse in malnourished 
patients by using OCD [14].  
Mete et al. (2018), Lee et al. (2013) did not distinguish between body composition but 
examined dietary intake [12,30]. If breathlessness is worse in those with poorer nutrition, then 
it may be associated with those that also have reduced 6-MWT.  
Furthermore, the benefit of nutritional interventio was examined in seven studies. Two studies 
were considered high quality while three were moderate and two were low. Five studies 
showed that body weight was significantly improved in the nutritional groups. However, it is 
noted that lower volumes may be more suitable as tho e given greater calories gained fat and 
lost FFMI [39].  
Lung function improved in the group with lower calories in the study by Planas et al. (2005) 
[39] but worsened in those given more calories. Yet, Broekhuizen et al. (2005) found lung 
function changes were not clinically significant but this study is at risk of chronology bias [40]. 
Furthermore, Sugwara et al. (2010) found that inspiratory pressures and quadricep muscle 
force increased following nutrition [41]. In contrast the higher quality study by van de Bool et 










between groups. Yet, a systematic review by Collins et al. (2013) showed by meta-analysis that 
respiratory muscle function was improved with supplementation [51]. 
Also, studies examined the effect of nutrition on exercise ability. Broekhuizen et al. (2005) and 
Sugwara et al. (2010) found that intervention improved 6-MWT [40,41].  
Yet, these were low quality studies which differ to the results of three other studies showing no 
significant change in exercise ability measured by 6-MWT or ISWT [42-44]. Yet, van de Bool 
et al. (2017) did show an increase in daily steps with nutrition which was continued at the 3-
month follow-up study [44, 50]. Collins et al. (2013) reported that four of five studies 
examining exercise reported that intervention improved exercise, but a meta-analysis was not 
possible. As mentioned, it is likely malnutrition affects exercise ability so perhaps longer 
duration of treatment is required to reverse this effect [51].  
Quality of life was not seen to improve in several studies (Table 1 and 2).  Sugwara et al. 
(2010) showed that intervention improved health related QOL, however, not being a blinded 
study there was a risk of bias [41]. Unfortunately, different tools to measure quality of life and 
breathlessness were used in the studies (Table 1 and 2). As a result, comparison between 
studies is challenging. In one study HADS did not improve between groups after initial 
treatment, yet, after a further 3 months there was a significant difference between groups 
[44,52]. In addition, exercise was not improved in the intervention group in comparison to the 
control group in any of the studies.  Nonetheless, it i  interesting that most of the studies 
combined nutrition programmes as part of pulmonary rehabilitation. Not all patients will be 
suitable for referral and those with more severe COPD may be housebound [53]. Therefore, 
there is potentially a gap in the current knowledge.  
Two studies examined the benefit of dietary education and counselling and both were of 










consumed more calories, increased their weight and improved quality of life and global health 
scores [47]. Yet, the increase in calories was not con inued after the programme. Although this 
study was at risk of design bias as it was non-blinded (Table 1 and 2). Similarly, Faroorqi et al. 
(2010) showed that an education programme could increase weight after three months which 
was maintained at one year [48] . However, this study was also at risk of transfer bias. In 
addition, hand-grip strength improved but this result did not remain significant at one year. 
Consequently, these studies show that dietary counselling is likely to have an important role on 
the management of malnutrition in COPD. Nevertheless, although it is seen as a positive event 
that patients have gained weight in the studies, it i  not clear to what level of nutrition patients 
with COPD need to reach in order to lower the risk of negative effects associated with 
malnutrition.   
More research which examines the impact of malnutrition on COPD is necessary. Given that 
most of the studies are cross-sectional, a longitudinal cohort study over 2-5 years should be 
conducted. The study should primarily examine the eff ct of malnutrition on COPD severity, 
quality of life and exercise ability. A sample size of approximately fifty COPD patients from 
each GOLD stage should be used. In addition, research should explore the long-term effect of 
nutritional support. It would seem appropriate to undertake a randomised control trial over one 
year which involves the use of nutritional supplements and education. Patients with a low BMI 
and FFMI would be recruited from the respiratory outpatient department. As many of the 
studies have small numbers, a sample size of 150 patients may be appropriate. Furthermore, the 
nurse is an important contact for the patient with COPD. The nurse may be the first health care 
professional that the patient with COPD meets. The patient will continue to have ongoing 
nurse-led appointments. As a result, the nurse might be ideally placed to assess and implement 










nurses providing education and support during the study. An additional part of this study would 
preferably examine whether nutritional support is co t-effective.  
Ideally, further studies should be done independent of pulmonary rehabilitation programmes. 
Conclusion 
 Malnutrition affects a high proportion of people with COPD. There are multiple ways in which 
malnutrition is being measured in studies including BMI and FFMI. Yet, malnutrition is 
affecting exacerbation rates and increasing hospital admission and associated costs. Mortality 
is significantly associated with malnutrition which infers that health care professionals have a 
duty to include malnutrition assessment into the car  of COPD patients. Furthermore, 
malnutrition worsens the patients’ exercise ability and potentially severity of disease and 
quality of life. Consequently, oral nutritional supplementation may help the patient by avoiding 
further weight loss and increasing FFMI. Yet, smaller volumes/calories to support intake may 
be more appropriate. Finally, education and advice on nutrition may offer short term effects at 
improving intake. This knowledge is imperative to health care professionals to allow holistic 
care to be delivered. Furthermore, if malnutrition is ot properly addressed then health care 
professionals may be failing the patient with COPD. Consequently, clinical practice must 
incorporate robust plans to monitor nutrition in COPD patients and tailor a nutrition plan with 
the patient that is regularly reviewed.  
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Type of study 


















Mean BMI=18.9kg/m2  
 
Underweight patients 
compared to normal 
weight  
Lung function, BMI, MUAC, 
mMRC 
Selection bias. 
Possible channelling bias 
(severe patients) 
16 




Setting not  specified  
BMI <20 kg/m2 
Comparison made 
between groups based on 
BMI.  
TNF-α, DLCO, MUAC, TSF Selection bias 22 
Gupta et al. 
 (2014) [28] 
Cross-sectional 
147 (139:8) 
Outpatient department  
 
Comparison made 
between groups based on 
BMI. 
BMI, Lung function  
Oxygen saturation  
Selection bias 16 




Hospital and home 
setting. 
Comparison made 
between groups based on 
BMI. 
Admission, BMI, 
Energy intake,  
Exacerbation rate 
Study design bias  24 




Exercise department  Comparison made 
between groups based on 
BMI and FFMI.  
BMI, FFMI, ISWT, 12-MWT, 
Arm and leg circumference, 
Hand-grip strength, Peak 
working capacity 
Selection bias. 
Study design bias by 
following people up post 
admission  
22 
Holst et al. 
(2019) [10] 
Cross-sectional 
79 (37: 42) 
Pulmonary rehabilitation 
centre 
Dietary intake below 
<75% compared to intake 
≥75% 
Dietary intake, Weight loss 
Symptom burden, 
Malnutrition risk , 6-MWT 
30-s CST 
Selection bias 
Study design bias (including 
people with conditions that 
may affect nutrition)  
23 





Hospital Comparison of those who 
died and had admissions  
Malnutrition, Mortality  
Admission Cost  
Selection bias 27 
Humphreys et 
al. (2008) [22] 
Cross-sectional study 
66 (32:34) 
Outpatient clinic and 
home setting.  
Comparison made 
between groups based on 
BMI and FFMI. 
BMI, FFMI, Dietary intake  





Katsura et al. 
(2005) [14] 






between groups based on 
BMI 
Lung function, Body 
composition, SGRQ, SF-36 
6-MWT, OCD 
Selection bias 24 






in five hospitals 
Dietary intake below 
<75% compared to intake 
≥75% 
Dietary intake, BMI, BODE 
6-MWT, Admission, mMRC 
Study design bias as 24-hour 










Luo et al. 
(2016) [16] 
Cross sectional study 
235 (184:51)  
Outpatient clinic Comparison between 
GOLD groups and FFMI  
GOLD, FFMI, Exacerbation  
6-MWT, mMRC, PImax 
PEmax 
Selection bias 
Study design bias(including 
people with conditions that 
may affect nutrition) 
24 




Pulmonary rehab centre 
 
Comparison between 
those identified as 
malnourished with those 
nourished 
BMI, FFMI, Lung function  
DLCO, 6-MWT, MRC 
Mortality  
Selection bias 27 







Recruited for a clinical 
trial  
Patients with low 
FFMIPMA were compared 




Potential recall bias  27 




46 centres Patients were compared 
based BODE, WODE and 
CODE 
 
Lung function, BMI, FFMI  
Functional Assessment of 
Chronic Illness Therapy score. 
6-MWT, BODE, 
CODE, WODE, Mortality  
Bias associated with using 
tools not validated  
29 





(80% were from this 
setting) and referred 
hospitalised patients 
Those at risk of 
malnutrition were 
compared to those that 
weren’t.  
Lung function, Exacerbation 
rate, MNA, Waist 
circumference, Dietary intake, 
mMRC 
Selection bias, Analysis bias 
Study design bias (recruiting 
some patients who were 
inpatient and including people 
with conditions that may 
affect nutrition 
20 
Mkacher et al. 
(2016) [19] 
Cross sectional study 
58 (58:0) 
Hospital setting Those with poor balance 
or at risk of falls  
compared to those who 
weren’t in terms of 
nutrition and physical 
ability.  
6-MWT, BMI, MNA,TUG 
Unipodal stance test,Tinetti 
test, Berg balance scale  
Selection bias 25 




Pulmonary rehab clinic Patients were split into 4 
groups  
Lung function, SMI, FFMI  
BMI, Mortality 
Selection bias 23 




Outpatients at 39 sites. Comparison of those 
identified as 
malnourished with those 
nourished.  
Lung function, SGRQ, MRC 
FFMI, FFM, BMI  
Study design bias (including 
people with conditions that 
may affect nutrition). 
25 
Yazdanpanah et 
al. (2010) [24] 
Cross sectional study 
63 (unknown) 
Patients were recruited 
when acutely unwell in 
hospital but were stable 
at the time of the study.  
Comparison of energy 
intake in comparison to 
lung function.  
Lung function  
Dietary intake  
Exacerbation  
Selection bias 
Study design bias ( including 
people with conditions that 















Type of study 


















Pulmonary rehabilitation  
BMI <30kg/m2 
Comparison between intervention group 
given energy bar and control group 
ISWT, SGRQ, Muscle 
strength, Calorie intake, MRC 
Selection bias 27 
Broekhuizen et 
al. (2005) [40] 
Retrospective control  
39 (30:9) 
Pulmonary rehab 
Inclusion based on BMI, 
FFMI and weight loss 
Comparison between group A given 
125ml drink and group B given 200ml 
drink 
  
Body weight, FFM, FM,  
Incremental bicycle, REE, 










Outpatient department  Given nutrition education, then followed 
up at 3 and 12 months.  
12-MWT, Hand-grip strength, 
Dietary intake  
Selection bias 
Transfer bias  
23 






Inclusion based on BMI, 
FFMI and weight loss 
Comparison of groups randomised to 
PRNS, PR or control  
MRC, BORG, 6-MWT, 




unblinded study  
26 
Planas et al. 





Inclusion based on BMI, 
FFMI and weight loss 
Comparison of group A and B based on 
additional calorie factors applied 
CRDQ, Weight, FFMI, Skin 
fold thickness, Lung function, 




Sugawara et al. 
(2010) [41] 
RCT 
32 (ratio not given) 
Pulmonary rehab centre 
 
Comparison of intervention to control  
 
Inflammation, 6-MWT, 
CRDQ, MRC, Energy intake  
Selection bias 
Bias - unblinded 
19 





Seven pulmonary rehab 
centres.FFMI below the 
normal range for age and 
sex 
Extension of Van de Bool et al. (2017) to 
measure the long-term effect  
Lung function, Quadricep 
muscle strength, DEXA, 
Bloods, Cost, Steps, HADS,  
EQ-5D 
Selection bias 31 
Van de Bool et 





Low free mass index 
Comparison of intervention group given 
drinks and control had a placebo drink.  
BMI, FFMI, SKM, CET, 
Quadricep muscle strength,  
6-MWT, Inspiratory muscle 





than intended  
32 
Weekes, Emery 






At risk of malnutrition 
measured by MUST   
Dietary education and milk fortification 
in comparison to the control group.  
Dietary intake, Weight, 





for). Bias – 














Records identified through 
database searching 


































Additional records identified 
through other sources 
(n = 13) 
Records after duplicates removed 
(n = 46) 
Records screened 
(n = 46) 
Records excluded 
(n = 16) 
Full-text articles assessed 
for eligibility 
(n = 30) 
Full-text articles excluded, 
with reasons 
(n = 1) Mentioned 
nutrition in title but 
examined muscle function 
(n=1) included 
participants with 
respiratory disease other 
than COPD  
Studies included in 
qualitative synthesis 
(n = 0) 
Studies included in 
quantitative synthesis  
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